Job Description
GLAUKOS SR. SCIENTIST II - DRUG DELIVERY INNOVATION
How will you make an impact?
This position supports research and development of intra-ocular drug delivery and/or glaucoma devices and inserters, and can also be a supervisor for the junior members of R&D staff, such as chemistry interns and chemist I positions. In addition to providing technical input to Applied Research projects, this position is expected to contribute to cross-functional teams within the company.
Glaukos is a small, entrepreneurial company where each person is responsible for many different functions. We are looking for a person who will flourish in this kind of environment - a hands-on, self-motivated individual who can develop new chemistries and analytical methods with minimal direction.
Want more jobs like this?
Get jobs in Aliso Viejo, CA delivered to your inbox every week.
What will you do?
API Formulations
- Characterize formulations for suitability in implant models
- Develop and conduct assay methods to quantify drug concentration in solutions by HPLC
- Participate in GMP builds of product for in vivo studies
- Characterize stability of API's by potency, purity, and impurity methods
- Advisory role, time cards, personnel issues
- Requires a Bachelor's degree in a S&T discipline (Chemistry, Chemical Engineering, or related discipline and 12+ years of related experience, or Master's degree and 10+ years of related experience, or PhD and 8+ years of related experience.
- The job will be described as development of biocompatible coatings for our stents.
- Biocompatible or bioactive molecule-eluting coatings (such as for cardiovascular stents or pacemaker leads), including pre-clinical validation, a strong plus.
- A versatile hands-on bench chemist, an individual contributor.
- Analytical methods such as HPLC-MS (High Performance Liquid Chromatography, Mass Spectroscopy).
About Us
Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible.
Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases.
Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients.
Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra "We'll Go First," which articulates our willingness to take chances, our determination to forge new ground, and our commitment to continuous improvement in all that we do.
Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol "GKOS". Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts.
Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.